Home » International News » 2011 » March » March 29, 2011

New Silk Route Expands Leadership Team with Addition of Global Healthcare Industry Veteran Supratim Bose as Partner

March 29, 2011 - New York, United States

New Silk Route, a leading Asia-focused private equity and growth capital firm focused on investing in private companies in the Indian sub-continent and other rapidly growing economies of south Asia, today announced that Supratim Bose has joined the firm as Partner. Based in Singapore, Mr. Bose will be responsible for sourcing investments and building a robust healthcare platform in Asia.

Supratim Bose (Photo: Business Wire)

Supratim Bose (Photo: Business Wire)

Mr. Bose joins New Silk Route from Bose Consulting Group, where he specialized in strategic management consulting services for the healthcare industry as founder and CEO. Prior to founding his own consulting firm, Mr. Bose served for 28 years with Johnson & Johnson Inc, and since 2003 was a member of the Worldwide Group Operating Committee Johnson & Johnson Medical Devices & Diagnostics Group, as Company Group Chairman. While at Johnson & Johnson, he pioneered the entry, designed the market creation strategies and led the growth of J&J Medical Devices & Diagnostics companies in all Asia-Pacific markets including emerging markets like China, India & Vietnam. Mr. Bose was also instrumental in implementing the strategy of Market Appropriate Products in Asia and setting up the first R&D and Product Development Centre in the region to develop products to meet the needs of Asian patients and surgeons, leading to the launch of several products tailored for emerging markets.

“Supratim is a well-respected leader in the healthcare industry whose accomplishments and expertise complement the significant international expertise and strong network of New Silk Route’s leadership team,” said Parag Saxena, New Silk Route’s CEO and co-founder. “With his location in Singapore and experience in the emerging markets in Asia, Supratim extends our reach beyond India into our other target investment regions in Asia, bringing a valuable global perspective and operational knowledge to our firm and portfolio companies.”

“I’m excited about the opportunity to join New Silk Route’s partnership and lead our development of a strong healthcare platform in Asia,” Mr. Bose said. “New Silk Route’s leadership team and local investment professionals have a unique understanding of India and the broader Asian region. Recognizing the significant investment opportunities presented by the healthcare industry, I’m looking forward to expanding New Silk Route’s geographic and sector reach, leveraging my 28 years with Johnson & Johnson in Asia.”

Mr. Bose is a member of the Board of Quattro Vascular Pte Ltd and Trireme Medical, served Singapore Management University as a member of the Advisory Board of the Lee Kong Chian School of Business and teaches in Nanyang Business School as visiting faculty. A native of Mumbai, India, Supratim earned a B.Sc. degree in Chemistry/Physics,an M.Sc. degree in Biophysics and a MMS (Master of Management Studies) degree from the Jamnalal Institute of Management Studies, University of Bombay.

About New Silk Route

New Silk Route is a leading Asia-focused private equity and growth capital firm founded in 2006 with $1.4 billion under management, focused on the Indian subcontinent, as well as other rapidly growing economies in Asia and the Middle East. The firm’s leadership team has a long track record of successfully building and leading global organizations. New Silk Route’s team of experienced investment professionals has deep relationships in a variety of sectors, while the firm’s geographical focus also leverages strong and historical cultural links that bind Asia and the Middle East. To learn more, please go to

Photos/Multimedia Gallery Available:


CONTACTS : Edelman Jenny Farrelly, +1-212-819-4807 or Moritz Kaffsack, +91 (22) 43530210 x213

Source: Business Wire India


Comment on this story